Sept 12 (Reuters) - Garofalo Health Care SpA GHC.MI :
* H1 TOTAL REVENUE EUR 166.3 MILLION VERSUS EUR 133.5
MILLION YEAR
AGO
* H1 NET PROFIT EUR 13.2 MILLION VERSUS EUR 9.8 MILLION YEAR
AGO
* FOR H2 2022 GROUP IS CONFIDENT IT CAN CONTINUE ITS GROWTH
PATH
WITH REVENUES, OPERATING EBITDA ADJUSTED EXPECTED TO BEAT 2021,
ALSO AT LIKE-FOR-LIKE PERIMETER
* GROUP CONFIRMS FOR 2022 ITS STRATEGIC FOCUS ON M&A DRIVEN
GROWTH
Further company coverage: GHC.MI
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587720920;))